2012
DOI: 10.1126/scitranslmed.3004371
|View full text |Cite
|
Sign up to set email alerts
|

Human Neural Stem Cells Induce Functional Myelination in Mice with Severe Dysmyelination

Abstract: Shiverer-immunodeficient (Shi-id) mice demonstrate defective myelination in the central nervous system (CNS) and significant ataxia by 2 to 3 weeks of life. Expanded, banked human neural stem cells (HuCNS-SCs) were transplanted into three sites in the brains of neonatal or juvenile Shi-id mice, which were asymptomatic or showed advanced hypomyelination, respectively. In both groups of mice, HuCNS-SCs engrafted and underwent preferential differentiation into oligodendrocytes. These oligodendrocytes generated co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
108
0
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 118 publications
(113 citation statements)
references
References 54 publications
4
108
0
1
Order By: Relevance
“…These seminal observations suggest that such cells represent a plausible cellular source for cell-based therapy of myelin disorders (1). Although several studies highlighted the impressive therapeutic potential of human fetal NPCs (2)(3)(4)(5), the allogeneic nature of the available NPCs has prevented the bench-tobedside translation of NPC-based therapy for these diseases. In search of an accessible, renewable, and nonimmunogenic source of myelin-forming cells, reprogramming strategies were designed to generate rodent or primate induced pluripotent stem cell-derived NPCs (iPS-NPCs) or oligodendrocyte progenitor cells (iPS-OPCs) (6)(7)(8).…”
Section: Introductionmentioning
confidence: 99%
“…These seminal observations suggest that such cells represent a plausible cellular source for cell-based therapy of myelin disorders (1). Although several studies highlighted the impressive therapeutic potential of human fetal NPCs (2)(3)(4)(5), the allogeneic nature of the available NPCs has prevented the bench-tobedside translation of NPC-based therapy for these diseases. In search of an accessible, renewable, and nonimmunogenic source of myelin-forming cells, reprogramming strategies were designed to generate rodent or primate induced pluripotent stem cell-derived NPCs (iPS-NPCs) or oligodendrocyte progenitor cells (iPS-OPCs) (6)(7)(8).…”
Section: Introductionmentioning
confidence: 99%
“…Although various fetal human preparations can mediate extensive myelination following engraftment into shiverer/rag2 mice [2][3][4], primary fetal cells are limited by the quantity of appropriate tissue samples and/or require extensive expansion in vitro before transplantation. The influence of the shiverer/rag2 environment on oligodendrocyte progenitor cell (OPC) specification and differentiation, and the applicability of these cell preparations for remyelination following acquired demyelination in adult CNS remain open questions.…”
Section: Introductionmentioning
confidence: 99%
“…Human OPCs have been directly isolated from brain tissue using a variety of surface antigen-based approaches (3)(4)(5)(6). In these studies, the rate of donor-derived myelination was dependent on both developmental stage and purity of the cell population.…”
mentioning
confidence: 99%